Page last updated: 2024-08-24

2,4,6-trihydroxyacetophenone and Obesity

2,4,6-trihydroxyacetophenone has been researched along with Obesity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Haro, JM; Jones, JW; Li, B; Tran, A; Wan, L; Xu, Z1
Correia, JF; de Oliveira, LF; Ferreira, EA; Filho, DW; Gris, EF; Pedrosa, RC; Rebello, JM1

Other Studies

2 other study(ies) available for 2,4,6-trihydroxyacetophenone and Obesity

ArticleYear
Lithium Hydroxide Hydrolysis Combined with MALDI TOF Mass Spectrometry for Rapid Sphingolipid Detection.
    Journal of the American Society for Mass Spectrometry, 2021, Jan-06, Volume: 32, Issue:1

    Topics: Acetophenones; Animals; Chromatography, High Pressure Liquid; Diet, High-Fat; Disease Models, Animal; Female; Hydrolysis; Lithium Compounds; Liver; Mice, Inbred C57BL; Obesity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sphingolipids; Workflow

2021
The 2',4',6'-trihydroxyacetophenone isolated from Myrcia multiflora has antiobesity and mixed hypolipidemic effects with the reduction of lipid intestinal absorption.
    Planta medica, 2011, Volume: 77, Issue:14

    Topics: Acetophenones; Animals; Anti-Obesity Agents; Cholesterol; Diet, High-Fat; Glucosides; Hypolipidemic Agents; Intestinal Absorption; Lactones; Lipase; Lipids; Lovastatin; Male; Mice; Myrica; Obesity; Orlistat; Pancreas; Plant Extracts; Rats; Rats, Wistar; Triglycerides; Weight Gain

2011